The molecular epidemiology and the antifungal susceptibility profiles of Candida albicans are scarce in Cameroon. Authors studied the genetic diversity and the antifungal susceptibility of C. albicans isolates from Yaoundé HIV-infected patients. Clinical isolates were obtained by mycological diagnosis of oropharyngeal swabs, stools, urine, and vaginal swabs from patients. C. albicans isolates were confirmed by the Light cycler real-time PCR of the ITS1 region of the 5.8s ribosomal DNA. The ABC genotypes and the Hwp1 gene amplification were carried out with specific primers. Microsatellite length polymorphism of HIS3, CDC3, and EF3 microsatellites was analysed. The antifungal susceptibility testing was carried out by the CLSI broth microdilution M27-A3 and M27-S4 protocols. The minimal inhibitory concentration (MIC) results were interpreted according to updated clinical breakpoints (CBPs) recommended by the CLSI or epidemiological cut-off values (ECVs). One hundred and thirteen (113) isolates were obtained from the analysis of 1218 samples. The ABC genotyping showed 79 (69.91%) genotype A, 24 (21.23%) genotype B, and 10 (8.84%) genotype C. The Hwp1 gene amplification provided a newly observed genetic polymorphism, named H and 5 genotypes described (H1-H5). The microsatellite analysis generated 65 molecular types. All the isolates were susceptible to amphotericin Ngouana et al.
Introduction
Mucosal Candida infections are common in patients infected with human immunodeficiency virus (HIV) and the morbidity and mortality associated to mucosal candidiasis depends on the colonized site. 1 The oropharyngeal candidiasis (OPC) is among the most encountered opportunistic infections in AIDS patients with a frequency between 50 and 95% in the sub-Saharan African region 2 . In Nigeria, Esebelahie et al. 3 recently described oropharyngeal colonisation
by Candida among 52.5% of HIV patients. A frequency of 79.6% was previously reported in Cameroon by Yongabi et al. 4 when studying candidiasis at the Yaoundé Central
Hospital. The most frequent manifestations of genitourinary candidiasis include vulvovaginal candidiasis (VVC) in women, balanitis in men, and candiduria in both genders. In a study by Oliveira et al. 5 , 29.7% of HIV-infected women develop vulvovaginal candidiasis (VVC). Urinary tract colonization by Candida species was about 4.84% among HIV-infected patients in a study by Newton et al. 6 Candida albicans is the principal agent responsible for this colonization though some other non-albicans Candida species are emerging as etiological agents of mucosal candidiasis. 3, 5, 6 C. albicans is diploid yeast belonging to the ascomycotina phylum. 7 The genetic of the yeast has widely been studied.
First described in 1999 by McCullough et al. 8 , the ABC genotyping was developed on the basis of the presence or absence of an insert in the DNA that encodes for the 25S ribosomal RNA among different C. albicans isolates. 8 The microsatellite analysis is a technique which has been used for molecular typing of C. albicans. 9, 10 A microsatellite is formed by short tandem repeats of two to six nucleotides known to be highly polymorphic, generating a characteristic profile of different alleles for a given locus. 11, 12 Due to its high discriminatory potential, [11] [12] [13] microsatellite analysis has been used to investigate the molecular profile of C. albicans from healthy individuals and HIV-positive patients. 1 The hyphal wall protein1 gene (Hwp1) is expressed in the filamentous form of the yeast. 14 
Materials and methods

Ethical considerations and enrollment of participants
The survey was carried out at the Yaoundé Central Hospital and involved HIV-infected patients. This study was approved by the Cameroonian National Ethical Committee.
Patients enrolled for this study were HIV-infected individuals of both genders, who did not receive any antifungal treatment during the last 3 months. The purpose of the study and potential benefits were explained to patients, and those willing to participate were required to sign a written informed consent prior to their registration as participant.
Vaginal discharge, oropharyngeal swab, stools, and urine were collected from each patient.
Mycological diagnosis
Samples were submitted to direct macroscopic and microscopic analyses using routine laboratory protocols prior to culture on Sabouraud chloramphenicol medium for 24 to 48 hours at 37 • C. Colonization was identified by culture quantification described by Bouchara et al. 15 
ABC genotyping
The ABC genotyping was assessed based on the differential PCR amplification of the 25S rRNA gene, as previously described. 8 
Hwp1 gene amplification
The Hwp1 gene amplification was first described for the discrimination between C. albicans complex species as follow: C. albicans 941 bp, C. dubliniensis 569bp, C. africana 700 bp, and C. stellatoidea type I 800 bp. 
Microsatellites analysis
The microsatellite markers consisted of one in the upstream sequence of the elongation factor 3 gene (EF3), located on chromosome 5, one downstream of the cell division cycle protein gene (CDC3), located on chromosome 1, and one downstream of the coding sequence for the imidazole 13 Amplified fragments were separated by electrophoresis using the high-resolution gel Spreadex EL 400 Wide Mini (Elchrom Scientific, Ebersberg, Germany). Migration profiles were recorded using GeneSnap and Genetools softwares (Syngene, UK). They were then entered into a database created with the Gene Directory software (Syngene, UK). Phylogenetic trees were generated through this last software, using multi-experiment comparison tool and UPGMA (Unweighted Pair Group with Arithmetic Mean) algorithms.
Antifungal susceptibility testing
The antifungal susceptibility testing was assessed as described by the CLSI M27-A3 protocol. 17 The correlation between susceptibility to antifungal drugs and genotypes was performed by the chi2 independent test at 95% confidence interval.
Results
From January 2012 to October 2013, 402 (306 females and 96 males) patients, aging between 23 and 66 years (mean age 40 ± 9) were included in the study. They were all infected by the HIV type I M, and one patient was coinfected with the HIV type I O. Their mean CD4 count was 371 ± 222 CD4/mm 3 with extremes at 34 and 1127 CD4/mm 3 . From these patients, 1218 biological samples were collected and analyzed, including 322 oropharyngeal swabs, 262 vaginal swabs, 308 stools, and 326 urine samples. Mycological diagnosis allowed identification of 317 yeast isolates, grouped into 21 yeast species from which 15 Candida and 6 non-Candida. The isolated Candida species were C. albicans species complex (n = 115), C. krusei (n = 55), C. glabrata (n = 33), C. tropicalis (n = 26), C. parapsilosis (n = 18), C. rugosa (n = 14), C. kefyr (n = 8), C. sake (n = 6), C. lusitaniae (n = 3), C. norvegensis (n = 3), Candida spp. (n = 21). Non-Candida species comprised Cryptococcus spp. (n = 2), Saccharomyces cerevisiae (n = 4), other (n = 9). Two isolates were identified as C. africana and have already been published. 20 The 113 C. albicans isolates were isolated from different collection sites as follow: 21 from vaginal swabs, 40 from stools, 9 from urine samples, and 43 from oropharyngeal swabs. 
ABC genotyping
The ABC genotyping of C. albicans isolates ( 
Hwp1 gene amplification
The Hwp1 gene amplification provided PCR profiles as shown in Figure 1 . C. albicans isolates provided PCR profiles that have not yet been published. We named the newly observed genetic diversity H and described 5 genotypes: H1 (≈941 pb), H2 (≈941 and ≈1080 pb), H3 (≈941 and ≈850 pb), H4 (≈941 and ≈1200 pb) and H5 (≈850 and ≈1080 pb). Their respective occurrences were H1, 57.52%; H2, 18.58%; H3, 16.81%; H4, 6.19%; and H5, 0.9%.
Microsatellite analysis
Each microsatellite amplified sequence showed significant polymorphism. The integration of the genetic diversity of the three microsatellite sequences for 109 of the 113 C. albicans isolates generated the dendrogram shown on Figure 2 . Analysis was carried out at 95% similarity and allowed identification of 65 molecular types. Some isolates defined a unique molecular type. Isolates from the same patient were found either in the same molecular type or in different molecular types. For example, the patient 470 presented isolates in clades 33 and 36 from oropharyngeal swab and stool, respectively. Different genotypes were found in each collection site and there was no association between genotypes and collection sites.
Antifungal susceptibility testing
The results of the antifungal susceptibility testing are presented in 
Discussion
C. albicans remains the main Candida species involved in mucosal colonisation among HIV-infected patients at the Figure 1 . Profiles obtained after agarose gel electrophoresis of Candida albicansHwp1 amplicons. M is the 100 bp molecular weight ladder. 357PV, 357U1, and 383B are isolates with two bands at ≈941 and ≈850 bp. 357S1 is a sample with two bands at ≈941 and ≈1080 bp. 363B and 388B are samples with two bands at ≈941 and ≈1200 bp. 358B, 360S, 373B, 373S, 374S, 378S, 381B, 384B, and 387PV are samples with one band at ≈941 bp. Yaoundé Central Hospital as we observed in the present study. The determination of other species of the C. albicans species complex exposed the real impact of C. albicans in mucosal colonization. 20 The ABC genotyping exhibited the predominance of the genotype A, followed by the genotype B as it has already been established. [21] [22] [23] Some studies obtained the genotype C as the more frequent. 22, 23 Multiple colonizations were observed in the same patient, noticeable by patients colonised by C. albicans strains of different genotypes (ABC genotyping), and this suggests multiple contaminations of a patient by different strains as previously hypothesized by Odds et al. 24 and Jacobsen et al. 25 Also, it was found isolates with the same genotype in different mucosae of the same patient, suggesting a migration of a unique strain from site to site as previously mentioned. 1 Moreover, any lesion of the gut mucosa can be exploited by the yeast to enter the blood causing candidemia. The diploid C. albicans yeast expresses the Hwp1 gene during the filamentation process. 14 Authors are establishing the first study of the genetic diversity of the Hwp1 gene in C. albicans. The diversity of this gene might be associated with high genetic variations in C. albicans. 26, 27 Microsatellite analysis is a good approach for typing strains of a species. 28 The HIS3, CDC3, and EF3 primers amplify microsatellite regions highly polymorphic for C. albicans. Moreover, these regions are stable over generations and were chosen because they are located on different chromosomes, which increases chances of finding polymorphisms. 1, 13 Botterel et al. 13 obtained a discriminatory power of 0.97 by combination of HIS3, CDC3, and EF3 microsatellite sequences for C. albicans typing. This work is the first molecular typing study of C. albicans isolates from Cameroon, and 65 molecular types were obtained with the 109 tested isolates. Such important genetic diversity was previously observed. 13, 29 Sampio et al. 12 obtained an important genetic diversity among C. albicans isolates using other microsatellite sequences (CAI, CEF, CAVI). The high number of molecular types might suppose the high dynamism of the C. albicans genome where translocations, deletions, and duplications are frequent. 26, 27 It was also noticed a similarity between genotypes of isolates from different collection sites. This suggests no relationship between mucosa and a particular genotype. Important recent advances in antifungal susceptibility testing include validation of 24 h reading times for all antifungal agents and the establishment of species-specific clinical breakpoints (CBPs) and epidemiological cutoff values (ECVs) for several commonly used antifungal agents. 18, 30 These modifications were taken in account for the study of the antifungal susceptibility of 113 isolates we tested. All of these isolates appeared to be susceptible to amphotericin B. The results highlight the effectiveness of that polyen against C. albicans isolates and also confirm the fact that very few numbers of C. albicans have developed reduced susceptibility to amphotericin B. 31 Fluconazole is distributed free of charge in Cameroon for the treatment of yeast infections among HIV-infected patients. The patients were not exposed to antifungals for at least 3 months prior to specimen collection. Tested isolates to that drug exhibited 9.74% of resistance. Lyon et al. 32 suggests that there is a relatively high proportion of isolates in Cameroon with reduced susceptibility to the drug. Itraconazole is not widely used in Cameroon, and the observed resistance might be associated to the resistance to other azoles like fluconazole, as the cross-resistance phenomenon is described in this case. 35 The results obtained in the present work highlight the important genetic diversity of C. albicans isolates amongst Yaoundé HIV infected patients and bring clues for the comprehension of the molecular epidemiology of the yeast in Cameroon. The first description of the genetic polymorphism of the Hwp1 gene requires further studies to better understand the implication of this phenomenon in the physiopathology and susceptibility of the yeast to antifungal drugs. The reduced susceptibility of isolates to azoles is of particular interest, and scrutiny of the resistance emergence should be active in Cameroon to provide good measures and alternatives for the antifungal therapy against mucosal candidiasis.
